Novartis pledges to eliminate leprosy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Dec, 2013
Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...Read more
AstraZeneca begins cancer research in Russia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed...Read more
Tachycardia holds room to grow: Report
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2012
Singapore: A rapid heart rate is a common condition among elderly individuals, and represents a potential goldmine for p...Read more
ETC, AstraZeneca form drug R&D partnership
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2013
Singapore: Experimental Therapeutics Center (ETC) and Exploit Technologies of Agency for Science, Technology and Researc...Read more
FDA approves Gilead's Stribild
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2012
Singapore: The US Food and Drug Administration (FDA) has approved Stribild, a complete once-daily single tablet regimen ...Read more
BNC105 effective in treating cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Bionomics is going to present clinical trial data from its ongoing US trial of BNC105 in patients with metast...Read more
QRxPharma pain killer's NDA gets FDA response
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 28 Aug, 2013
Singapore: QRxPharma received complete response letter (CRL) regarding the company's Moxduo new drug application (NDA) f...Read more
3SBio to develop JenKem's novel drug for cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2014
Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...Read more
Takeda to collaborate with BC Cancer Agency for new drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2012
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...Read more
Teva to acquire migraine drug firm at $825 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...Read more
Japan to help export regenerative medicine tech to Qatar, KSA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...Read more
Bayer receives approval for Gadovist injection in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Mar, 2015
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...Read more
New analysis of EndoBarrier reveals high efficacy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...Read more
Novartis announces positive results in COPD portfolio trials
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...Read more
Korea Drug Development Fund collaborates with PAREXEL
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2012
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...Read more
Non-small cell lung cancer therapeutics APAC market to touch $2.9 bn by 2019'
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 19 Mar, 2014
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...Read more
GSK announces failure of cancer drug trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2014
Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...Read more
Singapore invests $60mn to set up nanomedicine research institute
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore ...Read more